XML 38 R13.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Fair Value
9 Months Ended
Jul. 30, 2011
Fair Value [Abstract]  
Fair Value
Note 8 — Fair Value
     The Company defines fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
     Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
     Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability.
     Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. As of October 30, 2010 the Company held no assets or liabilities valued using level 3 inputs.
     The table below sets forth by level the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of July 30, 2011 and October 30, 2010. The table excludes cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value.
                                                         
    July 30, 2011     October 30, 2010  
    Fair Value measurement at             Fair Value measurement at        
    Reporting Date using:             Reporting Date using:        
    Quoted                             Quoted              
    Prices in                             Prices in              
    Active                             Active              
    Markets     Significant     Significant             Markets     Significant        
    for     Other     Other             for     Other        
    Identical     Observable     Unobservable             Identical     Observable        
    Assets     Inputs     Inputs             Assets     Inputs        
    (Level 1)     (Level 2)     (Level 3)     Total     (Level 1)     (Level 2)     Total  
Assets
                                                       
Cash equivalents:
                                                       
Available-for-sale:
                                                       
Institutional money market funds
  $ 1,285,049     $     $     $ 1,285,049     $ 921,034     $     $ 921,034  
Corporate obligations
          39,983             39,983             99,959       99,959  
Short — term investments:
                                                       
Available-for-sale:
                                                       
Securities with one year or less to maturity:
                                                       
Corporate obligations (1)
          2,123,434             2,123,434             1,520,220       1,520,220  
Floating rate notes, issued at par
                                  50,000       50,000  
Securities with greater than one year to maturity:
                                                       
Floating rate notes (1)
          17,664             17,664             17,548       17,548  
Other assets:
                                                       
Forward foreign currency exchange contracts (2)
          4,957             4,957             7,256       7,256  
Deferred compensation investments
    26,930                   26,930       8,690             8,690  
Other investments
    1,316                   1,316       1,317             1,317  
Interest rate swap agreements
          22,619             22,619             26,801       26,801  
 
                                         
Total assets measured at fair value
  $ 1,313,295     $ 2,208,657     $     $ 3,521,952     $ 931,041     $ 1,721,784     $ 2,652,825  
 
                                         
Liabilities
                                                       
Long-term debt
                                                       
$375 million aggregate principle 5.0% debt (3)
  $     $ 396,690     $     $ 396,690     $     $ 400,635     $ 400,635  
Contingent consideration (4)
                13,790       13,790                    
 
                                         
Total liabilities measured at fair value
  $     $ 396,690     $ 13,790     $ 410,480     $     $ 400,635     $ 400,635  
 
                                         
 
(1)   The amortized cost of the Company’s investments classified as available-for-sale as of July 30, 2011 and October 30, 2010 was $2,142.7 million and $1,639.1 million, respectively.
 
(2)   The Company has a master netting arrangement by counterparty with respect to derivative contracts. As of July 30, 2011 and October 30, 2010, contracts in a liability position of $0.6 million and $0.8 million, respectively, were netted against contracts in an asset position in the condensed consolidated balance sheets.
 
(3)   Equal to the accreted notional value of the debt plus the mark-to-market of the interest rate component of the long-term debt to fair value. The fair value of the long-term debt as of July 30, 2011 and October 30, 2010 was $413.5 million and $416.3 million, respectively.
 
(4)   As of July 30, 2011 there was no significant change to the fair value of the contingent consideration related to the Lyric acquisition since the date the acquisition was completed.
     The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments:
     Cash equivalents and short-term investments — These investments are adjusted to fair value based on quoted market prices or are determined using a yield curve model based on current market rates.
     Deferred compensation plan investments and other investments — The fair value of these mutual fund, money market fund and equity investments are based on quoted market prices.
     Long-term debt — The fair value of long-term debt is based on quotes received from third-party banks.
     Interest rate swap agreements — The fair value of interest rate swap agreements is based on quotes received from third-party banks. These values represent the estimated amount the Company would receive or pay to terminate the agreements taking into consideration current interest rates as well as the creditworthiness of the counterparty.
     Forward foreign currency exchange contracts — The estimated fair value of forward foreign currency exchange contracts, which includes derivatives that are accounted for as cash flow hedges and those that are not designated as cash flow hedges, is based on the estimated amount the Company would receive if it sold these agreements at the reporting date taking into consideration current interest rates as well as the creditworthiness of the counterparty for assets and the Company’s creditworthiness for liabilities.
     Contingent consideration — The fair value of contingent consideration was estimated utilizing the income approach and is based upon significant inputs not observable in the market. Changes in the fair value of the contingent consideration subsequent to the acquisition date that are primarily driven by assumptions pertaining to the achievement of the defined milestones will be recognized in earnings in the period of the estimated fair value change.
Financial Instruments Not Recorded at Fair Value on a Recurring Basis
     The Company accounts for its equity investments in privately held companies under the cost method. These investments are subject to periodic impairment review and measured and recorded at fair value when they are deemed to be other-than-temporarily impaired. The aggregate carrying value of the Company’s investments in privately held companies was approximately $2.0 million and was classified in other investments on the Company’s condensed consolidated balance sheets as of July 30, 2011. The Company did not have any investments in privately held companies as of October 30, 2010.
     On April 4, 2011, the Company issued $375 million aggregate principal amount of 3.0% senior unsecured notes due April 15, 2016 (the 3.0% Notes) with semi-annual fixed interest payments due on April 15 and October 15 of each year, commencing October 15, 2011. The fair value of the 3.0% Notes as of July 30, 2011 was $390.8 million.